Pagharion, Rowena .

HRN: 28-83-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
CO-AMOXICLAV 625MG (TAB)
04/10/2026
04/16/2026
PO
625 Mg
BID
Prom 11 Hrs
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: